Surgery Partners Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility S...
Latest News
9 hours ago · businesswire.com
SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share MergerNEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $23.50 per Share Merger.
3 days ago · globenewswire.com
SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold SharesNEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of Surgery Partners, Inc., you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/surgery-partners-merger-investigation.
4 days ago · newsfilecorp.com
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share MergerBFA Law is investigating the $23.50 per share merger, announced on October 26, 2026, in which Bon Secours Mercy Health, Inc. is set to acquire Surgery Partners, while Surgery Partners' largest stockholder, Bain Capital, is rolling over its equity into the post-merger entity; current stockholders are notified to contact the firm. New York, New York--(Newsfile Corp. - October 29, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware.
5 days ago · businesswire.com
SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA LawNEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law.
6 days ago · fool.com
Stock Market Today, Oct. 26: AI Optimism Lifts Nasdaq as Tech Stocks ReboundOn Oct. 26, 2026, Anthropic's IPO filing sparked a tech rally, while Meta's $95 billion AI infrastructure plan weighed on sentiment.
1 month ago · zacks.com
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
3 months ago · seekingalpha.com
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call TranscriptSurgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
3 months ago · zacks.com
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat EstimatesSurgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.
3 months ago · gurufocus.com
Is Surgery Partners Inc (SGRY) a Bargain After 3.1% Drop? GF Value Says UndervaluedOn July 31, 2026, Surgery Partners Inc (SGRY) shares fell 3.1% to a current price of $15.38. This decline comes amid a 52-week trading range of $11.41 to $24.10
3 months ago · zacks.com
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove SGRY